Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
35.3%
% of IHE's 34 holdings also in PPH
50.0%
% of PPH's 27 holdings also in IHE
Overlap by Weight
Sector Drift (IHE minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 23.4% | 12.2% | 12.2% |
|
JOHNSON & JOHNSON | 22.3% | 6.6% | 6.6% |
|
MERCK & CO. INC. | 4.8% | 6.2% | 4.8% |
|
PFIZER INC | 4.6% | 4.5% | 4.5% |
|
BRISTOL-MYERS SQUIBB CO | 4.5% | 4.4% | 4.4% |
Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to PPH
|
JOHNSON & JOHNSON | 15.7% |
|
ELI LILLY & CO | 11.2% |
|
ROYALTY PHARMA PLC CLASS A | 4.6% |
|
CATALENT INC | 3.2% |
|
VIATRIS, INC. | 2.6% |
|
INTRA-CELLULAR THERAPIES INC | 2.5% |
|
ELANCO ANIMAL HEALTH, INC. | 2.2% |
 |
JAZZ PHARMACEUTICALS PLC | 1.9% |
|
PRESTIGE BRANDS HOLDINGS INC | 1.4% |
|
ORGANON & CO. | 1.3% |
IHE Underweight Relative to PPH
 |
NOVO-NORDISK A/S-SPONS ADR | -9.5% |
|
ABBVIE INC | -5.8% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.2% |
 |
NOVARTIS AG-ADR | -4.8% |
|
AMERISOURCEBERGEN CORP | -4.7% |
|
MCKESSON CORP | -4.7% |
 |
SANOFI-AVENTIS-ADR | -4.5% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -4.4% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -4.2% |
 |
TEVA PHARMACEUTICAL-SP ADR | -2.9% |